Home/Filings/4/0001140361-13-034095
4//SEC Filing

UROPLASTY INC 4

Accession 0001140361-13-034095

CIK 0000890846operating

Filed

Aug 25, 8:00 PM ET

Accepted

Aug 26, 10:38 AM ET

Size

7.8 KB

Accession

0001140361-13-034095

Insider Transaction Report

Form 4
Period: 2013-08-22
Reynolds Brett
Senior V.P. CFO
Transactions
  • Purchase

    common stock

    2013-08-22$2.93/sh+3,700$10,83053,700 total
  • Purchase

    common stock

    2013-08-23$3.04/sh+4,300$13,07258,000 total
Holdings
  • non-qualified stock options

    Exercise: $2.97From: 2014-08-12Exp: 2021-08-11common stock (100,000 underlying)
    100,000
Footnotes (3)
  • [F1]Becomes exercisable with respect to one-third of the shares on the first, second and third anniversaries of the grant date (the grant date being one year prior to such date).
  • [F2]Includes 50,000 shares of restricted stock subject to risk of forfeiture that lapses with respect to one third of such shares on each of the first, second and third anniversaries of the grant date (August 12, 2013).
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.865 to $2.95 per share, inclusive.

Documents

1 file

Issuer

UROPLASTY INC

CIK 0000890846

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000890846

Filing Metadata

Form type
4
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 10:38 AM ET
Size
7.8 KB